第一财经网·2025-08-07 02:13Core Viewpoint - The current oversupply in the infant formula market does not support price increases, despite rumors of price hikes following the announcement of national childcare subsidies [1][3]. Group 1: Market Conditions - The domestic infant formula market is experiencing oversupply due to a continuous decline in the number of newborns, leading to intensified competition [1][3]. - The total number of children aged 0-3 in China has decreased from 50.1 million in 2018 to 28.5 million in 2023, contributing to market contraction [3]. - Approximately 70% of surveyed baby store owners reported that prices of infant formula have not increased, while about 30% noted price adjustments unrelated to childcare subsidies [3]. Group 2: Company Responses - Major companies such as Yili, China Feihe, and Beingmate have denied any price increases for their infant formula products, urging consumers not to believe in rumors [1]. - Beingmate stated on its investor interaction platform that all products have not seen price hikes and encouraged the public to refrain from spreading false information [1]. Group 3: Industry Trends - The infant formula industry is in a deep adjustment phase, with a slight recovery in sales observed in 2024, attributed to both a rebound in newborn numbers and the restoration of market order [4]. - Analysts indicate that the price stabilization in the infant formula market is a result of long-term strategic adjustments by companies, moving away from aggressive price competition [4].